number of cells available for studies such as drug testing or disease modeling." Cancer Dr. Roger Lo, MD, PhD—funding from the Melanoma Alliance. UCLA/ Jonson Comprehensive Cancer Center EFTA00710400 1. cancer cells quickly evolve to become resistant to inhibitor drugs. A research team from UCLA/JCCC, has mapped out how melanoma

number of cells available for studies such as drug testing or disease modeling." Cancer Dr. Roger Lo, MD, PhD—funding from the Melanoma Alliance. UCLA/ Jonson Comprehensive Cancer Center EFTA00862217 1. cancer cells quickly evolve to become resistant to inhibitor drugs. A research team from UCLA/JCCC, has mapped out how melanoma